Market Recap — April 23, 2026
Recap of insider activity, SEC filings, and market-moving news for April 23, 2026.
Top Importance Today
Filings and news with the highest AI-ranked importance score.
Scienjoy Reports Catastrophic $85.1M Net Loss for 2025, Driven by $83.7M Asset Impairment and Regulatory Headwinds
ESH Acquisition Corp. to Cease Operations, Redeem Public Shares, and Dissolve
Quartzsea Acquisition Corp Discloses Going Concern Doubt, Failed Merger, and Ineffective Internal Controls Amidst Looming Deadline
TruBridge to be Acquired by IKS Health for $26.25 Per Share in All-Cash Transaction
Cumberland Pharmaceuticals to Sell Commercial Business to Apotex for $100M, Shifts Focus to Orphan Drug Pipeline
Day One Biopharmaceuticals Completes $2.5B Acquisition by Servier, Delists from Nasdaq
Day One Biopharmaceuticals Confirms Merger Completion, Delisting from Nasdaq
Servier Completes Acquisition of Day One Biopharmaceuticals; Shares Delisted
Nasdaq to Delist zSpace Stock Days After Reverse Split Attempt
Nasdaq Issues Delisting Notice for zSpace, Inc.; Trading Suspension Imminent Despite Recent Reverse Split
Altimmune Finalizes $225M Public Offering at Discount, Significant Dilution Expected
Banks Hit Limits on Oracle's AI Debt, Future Data Center Expansion at Risk
No high-importance items captured for this date.
Largest Open-Market Insider Buys
Form 4 open-market purchases ranked by dollar amount.
Director & 10% Owner OrbiMed Buys $12.5M in Prelude Therapeutics Stock
OrbiMed Advisors, a Director and 10% Owner, Makes $12.5M Open Market Purchase in Prelude Therapeutics
CEO Daniel Wagner Buys $3.25M in Rezolve AI Shares at Premium Amidst Hostile Bid
Saba Capital Management, a 10% Owner, Increases Stake in Mexico Fund Inc. with $2.26M Open Market Purchase
No open-market insider buys reported on this date.
Largest Open-Market Insider Sells
Form 4 open-market sales ranked by dollar amount.
No open-market insider sells reported on this date.
Notable 8-Ks and News
Material events and breaking news with importance score 6 or higher.
ESH Acquisition Corp. to Cease Operations, Redeem Public Shares, and Dissolve
TruBridge to be Acquired by IKS Health for $26.25 Per Share in All-Cash Transaction
Day One Biopharmaceuticals Completes $2.5B Acquisition by Servier, Delists from Nasdaq
Nasdaq to Delist zSpace Stock Days After Reverse Split Attempt
Nasdaq Issues Delisting Notice for zSpace, Inc.; Trading Suspension Imminent Despite Recent Reverse Split
Banks Hit Limits on Oracle's AI Debt, Future Data Center Expansion at Risk
70% Plunge: Avis Budget Shares Crash as Short Sellers Win Hedge Fund Battle
Intel Surges 20% on Q1 Beat, Strong AI-Driven Q2 Forecast
Nasdaq Issues Delisting Notice to Sports Entertainment Gaming Global Corp for Delayed 10-K Filing
NEXTNRG Secures $500K in Highly Dilutive Debt with Punitive Terms Amidst Financial Distress
No notable 8-Ks or news items on this date.
Form 144 Notices
Notices that restricted shares may be sold soon — often a precursor to insider selling.
Baker Brothers Life Sciences Files Intent to Sell Over $1.6M in Protara Therapeutics Stock
Major Institutional Investor Files Intent to Sell Over $1.7M in Protara Therapeutics Stock
Officer James Hamilton Files to Sell $750K in ARWR Stock Near 52-Week High
Director Patrick Bowe Files Form 144 for 2,407 Shares, Continuing Recent Sales Pattern
Officer Files Intent to Sell $53.5K in Brag House Holdings Shares
No Form 144 notices filed on this date.
Day boundary: 00:00 ET (America/New_York). Filings accepted late may appear in the next day's recap.